✦ LIBER ✦

Inactivated hepatitis A virus vaccines

✍ Scribed by Stanley M. Lemon

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 538 KB
Volume: 15
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840150634

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inactivation of 1015 chimpanzee-infectio

Inactivation of 1015 chimpanzee-infectious doses of hepatitis B virus during preparation of a heat-inactivated hepatitis B vaccine

✍ Dr. P. N. Lelie; H. W. Reesink; J. Niessen; B. Brotman; A. M. Prince 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB

The safety of a plasma-derived hepatitis-B vaccine inactivated by two heating steps (90 sec at 103 "C followed by 10 hr pasteurization at 65 "C) was validated in chimpanzees; 1 O3 chimpanzee-infectious doses (CID,,) of hepatitis-B virus (HBV), subjected to the purification steps during production of

Hepatitis A virus: From discovery to vac

Hepatitis A virus: From discovery to vaccines

✍ Annette Martin; Stanley M. Lemon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 750 KB

## **Hepatitis A virus (HAV), the causative agent of type A viral hepatitis, is an ancient human virus that was first identified almost 35 years ago. It has several characteristics that make it unique among the** **Picornaviridae** **, particularly in terms of its mechanisms of polyprotein process

Immunogenicity of a hepatitis A virus va

Immunogenicity of a hepatitis A virus vaccine

✍ Bertram Flehmig; Angelika Haage; Mechthild Pfisterer 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 555 KB

Hepatitis A virus (HAV) strain HAV/HFS/GBM was adapted to and grown in human diploid fibroblast cells. The HAV was concentrated by ammonium sulphate precipitation and high-speed centrifugation. The virus was inactivated by beta-propiolacton and purified by sedimentation through a 20% solution of suc

Hepatitis B virus vaccines: Some cryptic

Hepatitis B virus vaccines: Some cryptic issues

✍ Subhash C. Arya 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 24 KB

Hepatitis B virus (HBV) is an infection with highest prevalences in Asia and sub-Saharan regions of the world where temperatures may vary widely, and where cold storage is not readily available. These are also regions where universal vaccination against HBV infection is essential to break the long-s

Long-term immunogenicity of an inactivat

Long-term immunogenicity of an inactivated virosome hepatitis A vaccine

✍ P.A. Bovier; J. Bock; L. Loutan; T. Farinelli; R. Glueck; C. Herzog 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

## Abstract The aim of this study was to predict the long‐term protection induced after immunisation with inactivated, aluminium‐free virosome hepatitis A vaccine. The study population consisted of adult volunteers enrolled in four different clinical trials. Lower 95% confidence interval limits and

An inactivated hepatitis A viral vaccine

An inactivated hepatitis A viral vaccine of cell culture origin

✍ P. J. Provost; J. V. Hughes; W. J. Miller; P. A. Giesa; F. S. Banker; E. A. Emin 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 516 KB

Hepatitis A virus (HAV) strain CR326, adapted to grow in LLC-MK2 cells, was highly purified, inactivated with formalin, adsorbed to alum, and tested for capacity to induce antibody to HAV in both mice and marmosets. The minimum dose of HAV antigen necessary to produce antibody in 50% of mice was 10